safer treatment
12/04/2017
/
By Ralph Flores
Plant cure for opioid addiction taking heat from the FDA: Claims of danger most likely linked to its impact on Big Pharma’s bottom line
Kratom, the popular plant-based opioid alternative from Southeast Asia, was the subject of an advisory from the Food and Drug Administration (FDA) on Tuesday, November 14, after the group called the substance “troubling” and blocked hundreds of kratom shipments to the U.S. In their statement, FDA Commissioner Scott Gottlieb reported that there are significant safety […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy